Marine ingredients
the industry can rely on

Algiecel builds non-fish marine ingredient supply: reliable, high-performing and produced at scale for humans and animals, without depending on finite natural resources.

Algiecel started with an engineering question rather than a biological one: not whether microalgae could produce valuable compounds via photosynthesis, but whether anyone could grow them consistently, affordably and at industrial scale.

Visualisation of modular photobioreactor units

That shaped our own photobioreactor design, a modular build format rather than a single large plant, and a commercial sequence that starts with whole biomass before moving to enriched fractions.

Where we are today

Physically, our production plant is in Kalundborg, Denmark.

Technically and commercially, whole biomass for pet food is the first commercial format, with omega-3 bio-oil, lipid fractions and protein fractions in development.

Leadership and board

A team drawn from industrial biotech, renewable energy and Nordic finance, building scalable production infrastructure for an ingredient category that does not yet have one.

Portrait of Susanne Palsten Buchardt

Susanne Palsten Buchardt

Chief Executive Officer

More than 25 years of international senior leadership and commercial experience across BioSolutions, renewable energy, agriculture, and animal health and nutrition, with prior roles at Novozymes, Ørsted and Bain & Company.

View LinkedIn
Portrait of Jesper Dohrup

Jesper Dohrup

Chief Technology Officer

Biochemical engineer, PhD by training and a 30+ year career in development, scale-up and technological market readiness at BioPhero, Ørsted, Alfa Laval, Arla Foods Ingredients and Haldor Topsoe.

View LinkedIn
Portrait of Ricardo Daura

Ricardo Daura

Chief Commercial Officer

More than 20 years as an international commercial and marketing strategist in agrifood, food and sustainable products, focused on customer acquisition and retention, with prior roles at AB Agri, Cargill and Wanadoo.

View LinkedIn
Mette Ingeman Pedersen

Mette Ingeman Pedersen

Chief Financial Officer

More than 20 years in senior finance, advisory and commercial roles across the Nordic region, including CFO of Topsoe’s Power-to-X business and senior finance leadership at Saxo Bank, Nordea and Danske Bank.

View LinkedIn

Industrial scale-up experience from European energy infrastructure, alongside founder and investor experience in bio-based industry.

Portrait of Tove Feld

Tove Feld

Board Professional.

Board member of: TRIG The Renewables Infrastructure Group, Venterra Group plc, Stockholm Exergi, DHI, Polytech, NEXEL

Portrait of Henrik Busch-Larsen

Henrik Busch-Larsen

Entrepreneur, Strategy, Vision, Execution, Scale-up.

Prior experience with CEO Unibio Group, Co-founder A21 Systems, Various Board Positions

Portrait of Martin Lavesen

Martin Lavesen

Managing Partner @DLA Piper Denmark.

Prior experience with +25 years as commercial lawyer focusing on IPR, Various board positions

Portrait of Jeppe Høier

Jeppe Høier

Investor.

Investor background from: Sunstone Life Science Ventures, Heartcore Maersk Growth. Led Unicorn rounds in companies such as Einride and Forto

Portrait of Merete Lundbye Møller

Merete Lundbye Møller

Venture Partner & General Counsel @Sunstone Life Science Ventures

Prior experience with: PreSeed Ventures, Curo Capital, Vækstfonden, Danish Green Investment Fund, Warehouse9, Hotel Pro Forma, Nalik Ventures

Valdemar Engel

Valdemar Engel

Investment Manager at EIFO Green Transition team.  Leading deeptech investments in energy, defense, biotech/biosolutions, and green industry from Seed to Series B. 

What Algiecel is not

Not a speculative research lab.

Not a single-compound extraction business.

Not a novel-ingredient story waiting on a discovery. We are building industrial production infrastructure for an ingredient category that needs it.

Contact us
White outline illustration of a photobioreactor